BIOMAT Database Logo BIOMAT Database Logo

Early and late patency of expanded polytetrafluoroethylene vascular grafts in aorta-coronary bypass. 1981

R N Sapsford, and G D Oakley, and S Talbot

Expanded polytetrafluoroethylene (PTFE) (Gore-Tex) grafts were used in 16 patients with ischemic heart disease undergoing aorta-coronary bypass graft operations. PTFE was used only when insufficient suitable vein was available. A total of 27 grafts were inserted in 16 patients. Eighteen grafts (in 11 patients) were studied in the early (3 months) postoperative period. Eleven were patent. Nine expanded PTFE grafts in six patients were restudied between 12 and 29 months after insertion. Six were patent. Factors affecting graft patency were similar to those governing patency of vein grafts. There was a high incidence of complications, but the patients constituted a poor-risk group. It is reasonable to use expanded PTFE grafts when insufficient vein is available. Such grafts can remain patent and functional for at least 2 years.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011138 Polytetrafluoroethylene Homopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron. FEP,Fluon,Politef,Polytef,TFE,Teflon,Expanded PTFE,Fluoroplast,GORE-TEX,Goretex,PTFE,Tarflen,GORE TEX,PTFE, Expanded
D001807 Blood Vessel Prosthesis Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels. Vascular Prosthesis,Blood Vessel Prostheses,Tissue-Engineered Vascular Graft,Graft, Tissue-Engineered Vascular,Grafts, Tissue-Engineered Vascular,Prostheses, Blood Vessel,Prostheses, Vascular,Prosthesis, Blood Vessel,Prosthesis, Vascular,Tissue Engineered Vascular Graft,Tissue-Engineered Vascular Grafts,Vascular Graft, Tissue-Engineered,Vascular Grafts, Tissue-Engineered,Vascular Prostheses,Vessel Prostheses, Blood,Vessel Prosthesis, Blood
D003251 Constriction, Pathologic The condition of an anatomical structure's being constricted beyond normal dimensions. Stenosis,Stricture,Constriction, Pathological,Pathologic Constriction,Constrictions, Pathologic,Pathologic Constrictions,Pathological Constriction,Stenoses,Strictures
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R N Sapsford, and G D Oakley, and S Talbot
Long-term patency of polytetrafluoroethylene vascular grafts in coronary artery surgery.
January 1985, The Annals of thoracic surgery,
R N Sapsford, and G D Oakley, and S Talbot
Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients.
July 1987, The Journal of thoracic and cardiovascular surgery,
R N Sapsford, and G D Oakley, and S Talbot
Extended patency of expanded polytetrafluoroethylene grafts for vascular access using optimal configuration and revisions.
January 1988, Surgery, gynecology & obstetrics,
R N Sapsford, and G D Oakley, and S Talbot
Lipid uptake in expanded polytetrafluoroethylene vascular grafts.
September 1998, Journal of vascular surgery,
R N Sapsford, and G D Oakley, and S Talbot
Femoropopliteal bypass: saphenous vein and expanded polytetrafluoroethylene grafts.
November 1982, Canadian journal of surgery. Journal canadien de chirurgie,
R N Sapsford, and G D Oakley, and S Talbot
The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery.
July 2014, Journal of vascular surgery,
R N Sapsford, and G D Oakley, and S Talbot
Late graft patency and symptom relief after aorta-coronary bypass.
February 1980, The Journal of thoracic and cardiovascular surgery,
R N Sapsford, and G D Oakley, and S Talbot
Aortocoronary bypass grafting with expanded polytetrafluoroethylene: 12-year patency.
May 1998, The Annals of thoracic surgery,
R N Sapsford, and G D Oakley, and S Talbot
Patency of coronary bypass grafts.
February 1977, The Journal of thoracic and cardiovascular surgery,
R N Sapsford, and G D Oakley, and S Talbot
Management of early and late thrombosis of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts: favorable prognosis with appropriate reoperation.
May 1980, Surgery,
Copied contents to your clipboard!